WiseBuzz announced on the 18th that it is establishing a dedicated team for US Direct‑to‑Consumer (DTC) advertising. The move aims to assist Korean pharmaceutical, biotech and healthcare companies in entering the US market.
DTC advertising allows companies to promote prescription drugs, medical devices and other health products directly to consumers. The United States is one of the few markets where prescription‑drug advertising to the general public is permitted, and several Korean firms already use DTC campaigns after expanding into the US.
WiseBuzz plans to run the DTC business as a core service, providing expertise and resources for Korean firms seeking to build brand awareness among US consumers.
Phân tích30 thg 8, 2026•1 phút đọc
WiseBuzz Forms US DTC Advertising Team to Support Korean Pharma Expansion
WiseBuzz announced the creation of a dedicated US Direct‑to‑Consumer advertising team to help Korean pharma and biotech firms launch DTC campaigns in the United States.
Tổng hợp bởi đội ngũ PharmaCountry · Nguồn: KPA News
Đánh giá
(0)
(0)
(0)
(0)
(0)
Bài viết khác
Xem tất cả bài viếtNghiên cứu & Báo cáo
Global Finished Dosage Manufacturing Landscape 2026
5 thg 10, 2026
Cập nhật pháp chếKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28 thg 9, 2026
Phân tíchPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28 thg 9, 2026
Để lại đánh giá